Stimulation of CD1d-restricted semiinvariant natural killer T cells by using the CD1d ligand ␣-galactosylceramide (␣GalCer) induces pregnancy loss in mice through an ill-defined mechanism involving TNF, IFN-␥, and perforin. In this article, we demonstrate that during early gestation, ␣GalCer efficiently induced pregnancy loss in C57BL͞6J and BALB͞cJ mice in a perforin-dependent manner. In contrast, during midgestation perforin was no longer required for pregnancy loss. Concomitant with the loss of a perforin requirement at midgestation was the emergence of strain-dependent variations in susceptibility to ␣GalCer-induced pregnancy loss. Whereas pregnant C57BL͞6J mice remained susceptible to ␣GalCer at midgestation, pregnant BALB͞cJ mice were resistant to its effects. Pregnancy loss during midgestation was correlated with dramatically higher serum cytokine levels, including TNF and IL-2, in the susceptible C57BL͞6J strain compared with the resistant BALB͞cJ strain. Thus, the stage of gestation defined two distinct mechanisms of pregnancy loss: a perforin-dependent mechanism operating at early gestation and a perforin-independent, cytokinedominated mechanism operating after midgestation.
I
ncreasing evidence suggests that unexplained cases of recurrent pregnancy loss and idiopathic preterm birth may have an underlying immune etiology (1, 2) . Innate immune mechanisms appear to play an especially critical role. Numerous studies suggest that aberrant natural killer (NK) cell activation is associated with recurrent pregnancy loss (3) (4) (5) (6) (7) , and there is a well-documented association of intrauterine infection with preterm birth (8, 9) . In addition, complement activation (10) or improper regulation of the complement system (11) has also been demonstrated to lead to pregnancy loss. A common thread throughout all of these mechanisms is the production of proinflammatory cytokines such as TNF, IL-1␤, and IFN-␥, which appear to be critical mediators in the induction of pregnancy loss at all stages of gestation (8, (12) (13) (14) (15) (16) (17) .
Semiinvariant NKT (iNKT) cells comprise a T cell subset that is present in both the human and mouse decidua (18) (19) (20) (21) . Unlike conventional T cells that recognize peptides in the context of polymorphic MHC molecules, iNKT cells recognize glycosphingolipids presented by the monomorphic class I MHC-like glycoprotein CD1d (22, 23) . Upon recognition of their glycosphingolipid ligands, iNKT cells rapidly produce a wide variety of cytokines including IFN-␥, IL-4, and TNF (22, 24) , and they possess the capacity for perforin-dependent cytotoxicity (25, 26) . Recently, iNKT cells were demonstrated to recognize cell wall glycosphingolipids from certain strains of bacteria (27) (28) (29) , adding to the growing body of evidence suggesting that iNKT cells are important in the clearance of pathogenic organisms (30) .
Stimulation of iNKT cells in pregnant mice by using the CD1d ligand ␣-galactosylceramide (␣GalCer) rapidly induces pregnancy loss in mice and has been proposed as a model of infection-associated pregnancy pathology (19) . In this article, we demonstrate that the mechanism through which iNKT cells mediate pregnancy loss is highly dependent on the stage of gestation, with early gestation pregnancy loss associated with a perforin-dependent lytic mechanism and midgestation pregnancy loss associated with a cytokine-dominated mechanism. We also found that midgestation, but not early gestation, pregnancy loss exhibited strain-dependent variations in proinflammatory cytokine production which correlated with susceptibility to iNKT cell-mediated pregnancy loss.
Results
iNKT Cell-Mediated Pregnancy Loss. iNKT cell activation in C57BL͞6J mice during early gestation pregnancy has been demonstrated to induce early gestation pregnancy loss (19) . We investigated the effect of ␣GalCer administration on pregnancy during later stages of gestation. Administration of ␣GalCer to pregnant C57BL͞6J mice at midgestation [day 9.5 postcoitus (p.c.)] induced rapid pregnancy loss with complete evacuation of the uterus by 72 h after injection, although remnants of fetoplacental units were occasionally seen (Fig. 1A) . Examination of uteri at earlier time points after ␣GalCer administration revealed individual resorbing embryos as early as 48 h after ␣GalCer administration (Fig. 1B) . Administration of ␣GalCer during late gestation (day 16.5 p.c.) resulted in the rapid onset of preterm birth. Within 18-24 h after receiving ␣GalCer, all mice delivered preterm fetuses complete with attached amnion and placenta (Fig. 1C) . No effect was observed in vehicleinjected mice (data not shown). Thus, activation of iNKT cells during pregnancy efficiently induced pregnancy loss at all stages of gestation in C57BL͞6J mice. Importantly, no effect was observed in mice deficient in iNKT cells (J␣18 Ϫ/Ϫ ) or in CD1d-deficient mice, indicating that the effect of ␣GalCer was solely due to its ability to stimulate iNKT cells in a CD1d-dependent manner (Table 1) .
Examination of the implantation sites after ␣GalCer administration revealed rapid histological changes. As early as 24 h after administration of ␣GalCer on day 9.5 p.c., the architecture of the labyrinthine zone of the placenta was noticeably disrupted compared with gestation-age matched controls ( Fig. 1 D and E) , and there was evidence of increased hemorrhage at the antimesometrial pole (data not shown). By 48 h, signs of deterioration of implantation sites were evident histologically, in part characterized by extensive fibrin deposition throughout the decidua (Fig. 1 F and G) . Gross dissection of these fetoplacental units revealed a mass of tissue without any discernible embryo. By 60 h, the presence of necrotic tissue in the lumen was observed (Fig. 1H) , as was the regeneration of the endometrial lining (Fig. 1I) .
Influence of Genetic Background During Early and Midgestation. Due to the conserved nature of the iNKT T cell receptor͞CD1d interactions, ␣GalCer efficiently stimulates iNKT cells from essentially all inbred mouse strains. Therefore, the ability of ␣GalCer to induce pregnancy loss was compared between C57BL͞6J and BALB͞cJ mice during early and midgestation. Although both strains experienced similar rates of pregnancy loss when ␣GalCer was administered during early gestation (day 6.5 p.c.), only C57BL͞6J was susceptible to iNKT cell-mediated pregnancy loss during midgestation ( Fig. 2A) . BALB͞cJ mice, in contrast, exhibited no overt signs of pregnancy loss at this stage of gestation. To explore this phenomenon further, we examined BALB͞cJ uteri at various times after administration of ␣GalCer on day 9.5 p.c. No increase in the rate of pregnancy loss was seen 3 or 6 days (days 12.5 and 15.5 p.c., respectively) after ␣GalCer administration (Fig. 2B) . Furthermore, when BALB͞cJ females were injected with ␣GalCer on day 9.5 p.c. and left to proceed to term, there was no significant decrease in litter size (Fig. 2C) . Thus, in contrast to C57BL͞6J mice, which were susceptible at all stages of gestation, BALB͞cJ mice were susceptible to iNKT cell-mediated pregnancy loss during early gestation but were resistant during midgestation.
To investigate these differences during midgestation further, we examined the effect of ␣GalCer in other strains of mice. None of the strains we examined exhibited any overt signs of pregnancy loss and, thus, were similar to the BALB͞cJ strain (Fig. 3A) . CBA͞J mice, however, did exhibit a marked increase in the frequency of resorbing embryos (Fig. 3B) , which corresponded to a significant decrease in the number of viable embryos (Table  2 ). An increase in resorption may also have occurred in B10.PL͞J, although, because of variability, a level of significance was not reached. C3H͞HeJ mice, in contrast, were completely resistant to the effect of ␣GalCer ( Fig. 3B and Table 2 ). Thus, iNKT cell-mediated pregnancy loss did not exhibit itself as an all-or-none phenomenon. Rather, a range of phenotypes was observed depending on the genetic background.
To examine more closely the influence of genetic background on iNKT cell-mediated pregnancy loss, we examined pregnant (BALB͞cJ ϫ C57BL͞6J)F 1 mice (CB6F1͞J). Although ␣GalCer administration at day 9.5 p.c. did not result in overt pregnancy loss in these mice (Fig. 3A) , it did result in a significant increase in the frequency of resorbing embryos compared with vehicleinjected controls (Fig. 3C) , which corresponded to a significant decrease in the number of viable embryos (Table 2) . Therefore, susceptibility to ␣GalCer-induced pregnancy loss was inherited as an incompletely dominant trait, suggesting complex genetic control. Collectively, these data suggested that, during midgestation, the genetic background was critical in dictating phenotypes of iNKT cell-mediated pregnancy loss that ranged from complete susceptibility to complete resistance. Timed pregnant C57BL͞6J and BALB͞cJ mice were administered ␣GalCer or vehicle control during early gestation (day 6.5 p.c) or midgestation (day 9.5 p.c.), followed by examination of the uteri on day 12.5 p.c. Data are presented as follows: (number of females pregnant at the time of euthanasia͞number of females with a vaginal plug)⅐100 (n ϭ 7-10 mice for each condition). * , P Ͻ 0.05. (B) ␣GalCer or vehicle control was administered to timed pregnant BALB͞cJ mice on day 9.5 p.c. Resorption rate was then calculated at various times after injection. No increase in resorption was observed out to day 15. E, vehicle-injected mice; F, ␣GalCer-injected mice. (C) Normal litter size in BALB͞cJ mice injected with ␣GalCer during midgestation. BALB͞cJ mice were injected on day 9.5 p.c. with vehicle or ␣GalCer and allowed to proceed to term. Data are presented as the number of live pups Ϯ SD (n ϭ 5 mice per condition). . ␣GalCer or vehicle control was administered to timed pregnant mice at day 9.5 p.c., and the resorption rate was calculated on day 12.5 p.c. E, vehicle-injected mice; F, ␣GalCer-injected mice. All animals were injected on 9.5 days p.c. and euthanized 72 h later. * , P ϭ 0.014; *** , P ϭ 0.001.
The Requirement for Perforin Depends on the Stage of Gestation. The fundamental differences between early and midgestation iNKT cell-mediated pregnancy loss suggested the possibility that there may be differences in the mechanisms of early and midgestation pregnancy loss induced by ␣GalCer. Because perforin had been demonstrated to be necessary for iNKT cell-mediated pregnancy loss (19), we investigated its requirement at different stages of gestation. ␣GalCer was administered to perforin-deficient mice (C57BL͞6 background) mice during early (day 6.5 p.c.) and midgestation (day 9.5 p.c.). Examination on day 12.5 p.c. revealed striking differences in their susceptibility to ␣GalCer. During early gestation, iNKT cell-mediated pregnancy loss was found to be completely dependent on perforin (Fig. 4) , confirming the findings of Ito et al. (19) . In contrast, administration of ␣GalCer during midgestation resulted in complete resorption of embryos, suggesting that it was not required for iNKT cell-mediated pregnancy loss during midgestation. No difference in serum cytokine levels between ␣GalCer-treated pregnant C57BL͞6J and perforin-deficient mice was observed, ruling out any indirect effects of perforin on cytokine production (data not shown). Therefore, these data suggested that iNKT cellmediated pregnancy loss occurs by two distinct mechanisms, a perforin-dependent mechanism operating early in gestation, and a perforin-independent mechanism operating during mid͞late gestation pregnancy loss. Taken together, these data indicated that the emergence of strain-dependent effects was inversely correlated with the requirement for perforin.
A Correlation Between Pregnancy Loss and Serum Cytokine Levels
During Midgestation. Next, we investigated the underlying differences between the C57BL͞6J and BALB͞cJ strains that accounted for their differing susceptibility to iNKT cell-mediated pregnancy loss at midgestation. Because IFN-␥ and TNF, like perforin, had been implicated in ␣GalCer-induced pregnancy loss during early gestation (19), we postulated that strain-dependent variation in the elaboration of these and other cytokines between C57BL͞6J and BALB͞cJ mice may have been responsible for the differential effect of ␣GalCer in these two strains. Pregnant C57BL͞6J and BALB͞cJ mice were injected with ␣GalCer on day 9.5 p.c., and blood was obtained at various times after injection for the measurement of serum cytokine levels. Levels of serum TNF, IL-2, and IL-4 increased rapidly and were highest 2 h after ␣GalCer administration (Fig. 5) . In contrast, serum IFN-␥ levels rose more slowly, reaching their highest levels 12 to 24 h after ␣GalCer administration (Fig. 5) , as has been observed in ref. 31 . Interestingly, levels of serum TNF, IL-2, and IL-4 were dramatically higher in resorbing C57BL͞6J mice compared with resistant BALB͞cJ mice. Levels of serum IFN-␥, in contrast, were similar between the two strains. Strain-dependent variation in serum cytokine production was not due to pregnancy because it was also observed in age-matched nonpregnant females (data not shown). Thus, during midgestation when perforin is not required, susceptibility to iNKT cell-mediated pregnancy loss is correlated with increased cytokine production resulting from iNKT cell stimulation.
Discussion
CD1d-restricted iNKT cells are a recently described unique T cell population known to accumulate in the decidua, but their physiological function there is unknown (18, 19) . In this article, we demonstrate that activation of iNKT cells results in both early gestation pregnancy loss and preterm birth and that there are distinct differences between the mechanisms operating at different stages of gestation. The data presented here support a model in which perforin-mediated and cytokine-mediated events are required in early gestation pregnancy loss and in which proinflammatory cytokines alone are sufficient to induce pregnancy loss at midgestation. Our data suggest that this switch from a perforin-dependent mechanism to a cytokine-dominated mechanism renders the pregnant mother susceptible to straindependent variations in proinflammatory cytokine production.
The mechanism through which perforin contributes to iNKT cell-mediated pregnancy loss remains unclear. As has been suggested, ␣GalCer may lead directly to perforin-dependent killing of fetal trophoblasts by iNKT cells (19) . Alternatively, NK cells, which have been demonstrated to be indirectly activated by iNKT cells (32) , may be the effectors ultimately responsible for mediating pregnancy loss. Perforin-containing NK cells are abundant at the maternal-fetal interface (33) (34) (35) , as are macrophages (36) and dendritic cells (37) , which have been implicated as intermediates in iNKT-NK cell signaling (38) . An iNKT-directed NK-dependent mechanism of immune-mediated pregnancy loss is also consistent with a recent article implicating NK cells in the disruption of the reproductive endocrine system through a TNF-dependent mechanism (39) . Unlike iNKT cell activation, however, which induced pregnancy loss at all stages Higher levels of serum cytokine production in mice destined for pregnancy loss. ␣GalCer was administered to pregnant C57BL͞6J and BALB͞c mice at day 9.5 p.c. Serum samples obtained at various time points after injection were assessed for cytokine levels. Levels of TNF, IL-2, and IL-4 reached their peak 2 h after administration of ␣GalCer and were present at significantly higher levels in serum from C57BL͞6J mice than from BALB͞cJ mice ( *** , P Ͻ 0.001; ** , P Ͻ 0.01). In contrast, the level of serum IFN-␥ reached a peak 12-24 h after administration of ␣GalCer, and there was little difference between the two strains. Mice injected with vehicle control did not exhibit increases in serum cytokines (data not shown). Each time point represents measurements from two to three pregnant mice. Fig. 4 . A requirement for perforin in early gestation, but not midgestation, pregnancy loss. Perforin Ϫ/Ϫ mice on a C57BL͞6J background were injected with ␣GalCer or vehicle on either day 6.5 or 9.5 p.c. Implantation sites were examined on day 12.5 p.c. Although perforin was required for the induction of early gestation pregnancy loss, it was completely dispensable during midgestation. Data are represented as mean resorption frequency Ϯ SD (n ϭ 5-7 mice for each condition). *** , P Ͻ 0.001.
of gestation, NK cell activation was only efficient during early gestation, suggesting the possibility that these two models may operate through common pathways in early gestation, but that iNKT cells must use independent mechanisms that allow it to mediate pregnancy loss after midgestation.
Concomitant with the switch from a perforin-dependent mechanism to a perforin-independent mechanism was the emergence of strain-dependent variation in the susceptibility to iNKT cell-mediated pregnancy loss. Susceptibility was correlated with increased production of serum cytokines, including TNF and IL-2, which have been associated with pregnancy loss (12, 40) . The observation that IL-4 was also elevated in susceptible C57BL͞6 mice argued against a bias in cytokine production. Rather, it suggested either increased activation or elevated numbers of iNKT cells in these mice. Although strain differences in iNKT cell number have been described in certain mouse strains (41, 42) , a previous study found no difference in the frequency of iNKT cells between C57BL͞6J and BALB͞cJ mice (43) . Therefore, genetic control of the ␣GalCer-elicited serum cytokine response may occur downstream of ␣GalCer-activated iNKT cells. Possible candidates are dendritic cells (44) , macrophages (38) , and NK cells (31, 45) , all of which have been demonstrated to function downstream of activated iNKT cells. Further analysis of these subsets will be necessary to determine their contribution to iNKT cell-mediated pregnancy loss.
The correlation between strain-dependent susceptibility to iNKT cell-mediated pregnancy and elevated serum cytokine levels was apparent at day 9.5 p.c., but not before. In mice, this stage of gestation coincides with the establishment of uteroplacental blood circulation (equivalent to Ϸ11-12 weeks in humans) (46) . It is possible, therefore, that newly developed vascularization of the placenta engenders new avenues of susceptibility to damage initiated by proinflammatory mediators. Possible mechanisms may be thrombotic events initiated by TNF and IFN-␥ (17) or direct cytotoxicity of trophoblasts by TNF (47) . It is also possible that TNF may induce production of proinflammatory lipid mediators that directly exert their effects on uterine smooth muscle (48, 49) . Thus, we speculate that gestation-dependent physiological changes in placental development render the embryo highly susceptible to variations in proinflammatory cytokine production.
The influence of genetic background on iNKT cell-mediated pregnancy loss suggests that it may be a useful model to investigate the links between proinflammatory cytokine production and preterm birth. Preterm birth in humans is linked to intrauterine infection (8, 9) . Human epidemiological studies have demonstrated an association between preterm birth and certain TNF gene polymorphisms (14, 50, 51) . Taken together, the ability of iNKT cells to rapidly secrete large amounts of cytokines, the recent demonstration that they are capable of recognizing certain bacterial glycosphingolipids (27) (28) (29) , and our data demonstrating that susceptibility to iNKT cell-mediated pregnancy correlates with straindependent variations in TNF production suggests a potential role for these cells in infection-associated preterm birth.
Materials and Methods
Mice. C57BL͞6J, BALB͞cJ, CBA͞J, C3H͞HeJ, B10.PL, CB6F1͞J, and perforin-deficient (C57BL͞6-Prf1 tm1sdz ͞J) mice were purchased from The Jackson Laboratory. Perforin Ϫ/Ϫ mice were generated on a C57BL͞6J background. CD1d-deficient mice were bred onto the C57BL͞6 background for six generations (52) . J␣18 Ϫ/Ϫ mice were kindly provided by M. Taniguchi (RIKEN Institute, Yokohama City, Japan) and were generated as described in ref. 53 . All mice used in these experiments were between 6 and 8 weeks of age and were maintained in ventilated racks in sterile cages in a specific pathogen-free facility. All experiments were performed with the approval of the Institutional Animal Care and Use Committee.
Induction of Abortion by ␣GalCer. Timed pregnant syngeneic matings were conducted by using a single pair of mice per cage. The morning of detection of the vaginal plug was considered day 0.5 p.c. Pregnant females were separated in individual cages and given food and water ad libitum. ␣GalCer (a gift from Kirin Pharmaceuticals, Tokyo) resuspended in vehicle (PBS, pH 7.2͞ 0.5% polysorbate-20) or vehicle alone was delivered i.p. in a 100-l volume. Except where indicated, ␣GalCer was administered at a dose of 100 g͞kg. Mice were killed by CO 2 asphyxiation, followed by removal of the uterus to assess the status of pregnancy and for macroscopic examination and subsequent histological analysis of the fetoplacental units. Unless otherwise indicated, mice were euthanized on day 12.5 p.c. At this stage of gestation, fetoplacental units undergoing resorption can be clearly distinguished from their viable counterparts on the basis of size and the presence of extensive tissue wasting and hemorrhage. The resorption rate was calculated as follows: (number of resorbing embryos͞total number of embryos)⅐100. The pregnancy rate was calculated as follows: (number of females pregnant at the time of euthanasia͞number of females with a vaginal plug)⅐100.
Histology and Immunohistochemistry. For hematoxylin͞eosin staining, individual fetoplacental units were fixed overnight at 4°C in Bouin's fixative (Sigma-Aldrich) after which they were washed in an ethanol͞xylene series before paraffin embedding. Sections (7 m) were rehydrated and stained with Gill's hematoxylin͞ eosin according to standard procedures.
For immunohistochemical analysis, individual fetoplacental units were fixed overnight at 4°C in freshly prepared 4% paraformaldehyde in PBS, pH 7.2, after which they were washed in an ethanol͞xylene series before paraffin embedding. Serial sections (7 m) were rehydrated in PBS, pH 7.2, after which they were incubated in 3% hydrogen peroxide in methanol for 5 min. Sections were washed in PBS, then stained with rabbit antifibrinogen͞fibrin (DAKO) or with normal rabbit antisera (Jackson ImmunoResearch) for 2 h at room temperature. Staining was visualized by using a streptavidin ABC system with diaminobenzidine as a substrate (Vectastain; Vector Laboratories).
Serum Cytokine Analysis. Timed pregnant mice were injected with either ␣GalCer (100 g͞kg, i.p.) or vehicle control on day 9.5 p.c. Blood was obtained from the tail vein at various times after injection. Separate mice were used for each time point. All serum samples were frozen at Ϫ20°C until they were used for cytokine measurements. Serum cytokine levels were measured by using cytometric bead arrays according to the manufacturer's instructions (BD Biosciences Pharmingen). Diluted serum (50 l) was incubated with cytometric beads and a mixture of phycoerythrin-labeled anti-cytokine mAbs for 2 h at room temperature. Beads were washed once and then analyzed immediately by FACS (Becton Dickinson). A standard curve of each cytokine was generated in parallel. Collected FACS data were analyzed by using CBA software (BD Biosciences Pharmingen).
Statistics. Pregnancy rates were evaluated in 2 ϫ 2 contingency tables by using Fisher's exact test. Tests for differences in serum cytokine responses were performed by using two-way ANOVA with Bonferroni post hoc analysis. All other tests were evaluated by using the Mann-Whitney rank-sum test. P values Ͻ 0.05 were considered significant.
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